These displayed significant inhibitions of cell proliferation in THP1 cells and primary AML patient blasts, inducing differentiation and apoptosis (Figs. S3A–S3G) with minimum effect on normal human CD34+ BM HSPCs (Fig. S3E). The gene discussed is CD34; the disease is acute myeloid leukemia.